INTRODUCCIÓN: REVISIÓN CRITICA DEL PROBLEMA

CAPÍTULO VIII
128. Sugaya K, Fukagawa T, Matsumoto K, Mita K, Takahashi E, Ando A, Inoko H, Ikemura T.
Three genes in the human MHC class III region near the junction with the class II: gene
for receptor of advanced glycosylation end products, PBX2 homeobox gene and a notch
homolog, human counterpart of mouse mammary tumor gene int-3. Genomics. 1994 Sep
15;23(2):408-19.
129. Peiser L, Mukhopadhyay S, Gordon S. Scavenger receptors in innate immunity. Curr Opin
Immunol. 2002 Feb;14(1):123-8.
130. Vlassara H, Brownlee M, Cerami A.Novel macrophage receptor for glucose-modified
proteins is distinct from previously described scavenger receptors. J Exp Med. 1986 Oct
1;164(4):1301-9.
131. Herold K, Moser B, Chen Y, Zeng S, Yan SF, Ramasamy R, Emond J, Clynes R, Schmidt
AM. Receptor for advanced glycation end products (RAGE) in a dash to the rescue:
inflammatory signals gone awry in the primal response to stress. J Leukoc Biol. 2007
Aug;82(2):204-12.
132. Lin L. RAGE on the Toll Road? Cell Mol Immunol. 2006 Oct;3(5):351-8. Review.
133. Sousa MM, Yan SD, Stern D, Saraiva MJ. Interaction of the receptor for advanced glycation
end products (RAGE) with transthyretin triggers nuclear transcription factor kB (NF-kB)
activation. Lab Invest. 2000 Jul;80(7):1101-10.
134. Dukic-Stefanovic S, Gasic-Milenkovic J, Deuther-Conrad W, Münch G. Signal transduction
pathways in mouse microglia N-11 cells activated by advanced glycation endproducts
(AGEs). J Neurochem. 2003 Oct;87(1):44-55.
135. Liu Y, Liang C, Liu X, Liao B, Pan X, Ren Y, Fan M, Li M, He Z, Wu J, Wu Z. AGEs
increased migration and inflammatory responses of adventitial fibroblasts via RAGE,
MAPK and NF-kappaB pathways. Atherosclerosis. 2010 Jan;208(1):34-42.
136. Yeh CH, Sturgis L, Haidacher J, Zhang XN, Sherwood SJ, Bjercke RJ, Juhasz O, Crow MT,
Tilton RG, Denner L. Requirement for p38 and p44/p42 mitogen-activated protein kinases
in RAGE-mediated nuclear factor-kappaB transcriptional activation and cytokine
secretion. Diabetes. 2001 Jun;50(6):1495-504.
137. Gao ZQ, Yang C, Wang YY, Wang P, Chen HL, Zhang XD, Liu R, Li WL, Qin XJ, Liang X,
Hai CX. RAGE upregulation and nuclear factor-kappaB activation associated with ageing
rat cardiomyocyte dysfunction. Gen Physiol Biophys. 2008 Sep;27(3):152-8.
138. Yan SD, Schmidt AM, Anderson GM, Zhang J, Brett J, Zou YS, Pinsky D, Stern D.
Enhanced cellular oxidant stress by the interaction of advanced glycation end products
with their receptors/binding proteins. J Biol Chem. 1994 Apr 1;269(13):9889-97.
139. Li Q, Verma IM. NF-kappaB regulation in the immune system. Nat Rev Immunol. 2002
Oct;2(10):725-34.
140. Yamamoto Y, Gaynor RB. IkappaB kinases: key regulators of the NF-kappaB pathway.
Trends Biochem Sci. 2004 Feb;29(2):72-9.
141. Henkel T, Machleidt T, Alkalay I, Krönke M, Ben-Neriah Y, Baeuerle PA. Rapid proteolysis of
I kappa B-alpha is necessary for activation of transcription factor NF-kappa B. Nature.
1993 Sep 9;365(6442):182-5.
142. Bierhaus A, Schiekofer S, Schwaninger M, Andrassy M, Humpert PM, Chen J, Hong M,
Luther T, Henle T, Klöting I, Morcos M, Hofmann M, Tritschler H, Weigle B, Kasper M,
Smith M, Perry G, Schmidt AM, Stern DM, Häring HU, Schleicher E, Nawroth
PP.Diabetes-associated sustained activation of the transcription factor nuclear factorkappaB.
Diabetes. 2001 Dec;50(12):2792-808.
143. Häcker H, Karin M. Regulation and function of IKK and IKK-related kinases. Sci STKE. 2006
Oct 17 (357):13.
144. Rauvala H, Rouhiainen A. RAGE as a receptor of HMGB1 (Amphoterin): roles in health and
disease. Curr Mol Med. 2007 Dec;7(8):725-34. Review.
145. Donato R. RAGE: a single receptor for several ligands and different cellular responses: the
case of certain S100 proteins. Curr Mol Med. 2007 Dec;7(8):711-24. Review.
232